Fever-Tree's share price falls to a three-year low as the gin boom cools
Shares in drinks and mixers group Fever-Tree have fallen to a three-year low.

Shares in drinks and mixers group Fever-Tree slid by a fifth early this week, says Joanna Bourke in the Evening Standard. Founder and CEO Tim Warrillow has blamed a “subdued end to the year in the UK” for a 1% fall in UK sales and has warned that Fever-Tree’s “much vaunted” expansion into the US will suffer “slower growth than before”.
The warning has reduced the stock price to a three-year low. Fever-Tree’s market value has declined to £1.76bn, down from a peak of £4.5bn 18 months ago. While Fever-Tree’s management has attempted to cushion the blow with talk about “good momentum outside the UK” and has promised that home sales will “return to growth”, this is more than just a temporary blip, says Kate Burgess in the Financial Times. Competition from rival soft drinks firms is “hotting up” while the “craze” for gin and tonic “is turning”. What’s more, a “smallish British company” like Fever-Tree will find it harder than it thinks to break into the US market: building a brand is “challenging” and distribution is “tough”. Still, all is not lost . A buyer “with pockets deep enough to break the US” could snap it up.
Don’t be so sure, says Andrea Felsted on Bloomberg. A potential acquirer will first want to see evidence “that the company is stabilising”. After all, Fever-Tree’s attraction to shareholders come from its “fast growth”, and while 10% revenue expansion “is still much better” than the pace seen in consumer goods or food retail, it’s hardly impressive by Fever-Tree’s recent standards.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
Matthew graduated from the University of Durham in 2004; he then gained an MSc, followed by a PhD at the London School of Economics.
He has previously written for a wide range of publications, including the Guardian and the Economist, and also helped to run a newsletter on terrorism. He has spent time at Lehman Brothers, Citigroup and the consultancy Lombard Street Research.
Matthew is the author of Superinvestors: Lessons from the greatest investors in history, published by Harriman House, which has been translated into several languages. His second book, Investing Explained: The Accessible Guide to Building an Investment Portfolio, is published by Kogan Page.
As senior writer, he writes the shares and politics & economics pages, as well as weekly Blowing It and Great Frauds in History columns He also writes a fortnightly reviews page and trading tips, as well as regular cover stories and multi-page investment focus features.
Follow Matthew on Twitter: @DrMatthewPartri
-
Is the AI boom another dotcom bubble?
25 years on from the dotcom bubble bursting, is it time for investors to consider the sustainability of the AI boom in the stock market?
By Dan McEvoy Published
-
What is the S&P 500?
The S&P 500 is one of the world’s most popular stock market indices and has almost tripled in value over the last decade. But what is the S&P 500, and which companies does it contain?
By Daniel Hilton Published